FDCP
MRK icon

Foster Dykema Cabot & Partners’s Merck MRK Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Hold
8,626
– – 0.06% 48
2026
Q1 		$1.04M Sell
8,626
-234
-3% -$27K 0.07% 47
2025
Q4 		$940K Sell
8,860
-1,337
-13% -$126K 0.06% 51
2025
Q3 		$864K Buy
10,197
+779
+8% +$64.2K 0.06% 60
2025
Q2 		$753K Hold
9,418
– – 0.05% 62
2025
Q1 		$853K Sell
9,418
-2,481
-21% -$232K 0.07% 49
2024
Q4 		$1.19M Sell
11,899
-331
-3% -$34.1K 0.09% 47
2024
Q3 		$1.4M Buy
12,230
+2,681
+28% +$319K 0.12% 40
2024
Q2 		$1.19M Sell
9,549
-100
-1% -$12.9K 0.11% 39
2024
Q1 		$1.28M Buy
9,649
+850
+10% +$105K 0.12% 39
2023
Q4 		$966K Buy
+8,799
New +$913K 0.1% 42

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Foster Dykema Cabot & Partners's MRK Position: Q2 2026 in Review

Foster Dykema Cabot & Partners held its Merck (MRK) position steady in Q2 2026 at 8,626 shares worth $1.12M. The position accounts for 0.06% of the portfolio, ranked #48.

Foster Dykema Cabot & Partners first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.4M in Q3 2024. 3,834 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Foster Dykema Cabot & Partners held 8,626 shares of Merck worth $1.12M as of Q2 2026.
  • Foster Dykema Cabot & Partners left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.06% of Foster Dykema Cabot & Partners's portfolio in Q2 2026, its #48 holding.
  • Foster Dykema Cabot & Partners first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Foster Dykema Cabot & Partners's Merck position peaked at $1.4M in Q3 2024.
  • 3,834 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q2 2026, filed 11 Aug 2026.